Rankings / Longevity — Supplements
Lutein + Zeaxanthin
Longevity · Macular xanthophyll carotenoid
Tier A+
Bottom line
Read Off Label grades Lutein + Zeaxanthin as A+ (8.2/10) based on strong evidence, moderate-high benefit magnitude, and a low-risk safety profile.
AREDS2 replaced AREDS1's beta-carotene with lutein/zeaxanthin precisely because the carotenoid had Phase III trial data linking it to lung cancer in smokers.
Studied, labeled, or reported-use context: 10 mg lutein + 2 mg zeaxanthin/day (AREDS2 doses); food sources include kale, spinach, egg yolks (high… — OTC; not individualized guidance.
What the evidence says
AREDS2 replaced AREDS1's beta-carotene with lutein/zeaxanthin precisely because the carotenoid had Phase III trial data linking it to lung cancer in smokers. The macular pigment data is one of the cleanest carotenoid stories in clinical literature. Comparative studies report higher lutein bioavailability from the egg-yolk matrix than from spinach.
Mechanism
Selectively concentrated in the macula of the retina (macular pigment); absorb blue light; quench singlet oxygen and lipid peroxyl radicals; also concentrate in brain (especially frontal cortex) and may modulate cognition
Studied, labeled, or reported dose & route
10 mg lutein + 2 mg zeaxanthin/day (AREDS2 doses); food sources include kale, spinach, egg yolks (high bioavailability), corn
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Lutein + Zeaxanthin's effects?
- Read Off Label rates the evidence for Lutein + Zeaxanthin as Strong and the benefit magnitude as moderate-high, producing an overall grade of A+ (8.2/10). AREDS2 replaced AREDS1's beta-carotene with lutein/zeaxanthin precisely because the carotenoid had Phase III trial data linking it to lung cancer in smokers.
- What safety findings are reported for Lutein + Zeaxanthin?
- Lutein + Zeaxanthin has a low risk profile in the database. Low (much safer than beta-carotene — no smoker lung cancer signal in AREDS2; rare yellow skin discoloration at very high intake) Legal status: OTC.
- What doses or routes are reported for Lutein + Zeaxanthin?
- 10 mg lutein + 2 mg zeaxanthin/day (AREDS2 doses); food sources include kale, spinach, egg yolks (high bioavailability), corn This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Lutein + Zeaxanthin work?
- Selectively concentrated in the macula of the retina (macular pigment); absorb blue light; quench singlet oxygen and lipid peroxyl radicals; also concentrate in brain (especially frontal cortex) and may modulate cognition
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.